GSK3536820A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK3536820A, covering 2021-02-09 to 2021-02-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age [Phase 2]